Cargando…
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
The Affordable Care Act included a provision to gradually eliminate the Medicare prescription drug coverage gap between 2011 and 2020, which substantially lower medication costs in the gap. Using 2007–2016 Medicare claims data, we estimate how filling the gap affects individuals' out‐of‐pocket...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898097/ https://www.ncbi.nlm.nih.gov/pubmed/36399360 http://dx.doi.org/10.1002/hec.4637 |